论文部分内容阅读
本文报告用卡介苗素治疗支气管哮喘,收到满意效果。 1 临床资料 96例患者中男46例,女50例,年龄15～55岁,15～25岁25例,25～35岁25例,35～45岁26例,45～55岁20例。诊断标准:有反复发作的支气管哮喘史,大多数幼年发病,可找到发作的诱因,发作时有哮鸣的呼吸困难,肺部有普遍的哮鸣音,支气管解疼剂得以缓解,肺部X线未见特殊改变,可有肺气肿征象,部分有肺纹理增租及炎症阴影。96例支气管哮喘病者均符合上述诊断标准,治疗方法:隔日肌注卡介苗素针1支,3个月1疗程,每个病者必须完成1个疗程,不得中断,同时嘱病者避免接触各种过敏源。随访3年。
This article reports the use of BCG in the treatment of bronchial asthma, and received satisfactory results. A clinical data of 96 patients, 46 males and 50 females, aged 15 to 55 years, 15 to 25 years in 25 cases, 25 to 35 years in 25 cases, 35 to 45 years in 26 cases, 45 to 55 years in 20 cases. Diagnostic criteria: history of recurrent bronchial asthma, most of the juvenile onset, can find the cause of the attack, onset of wheezing breathing difficulties, the lungs have a common wheeze, bronchial pain reliever to ease the lung X Line no special changes, there may be signs of emphysema, some increased lung markings and inflammation of the shadow. 96 cases of bronchial asthma patients are in line with the above diagnostic criteria, treatment: every other day intramuscular injection of BCG a needle, 3 months 1 course of treatment, each patient must complete a course of treatment, shall not be interrupted, and instruct patients to avoid contact with the Allergens. Followed up for 3 years.